Paclitaxel hypersensitivity revisited.
Essayan
D M
DM
Kagey-Sobotka
A
A
Lichtenstein
L M
LM
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use; D003888:Desensitization, Immunologic; D004342:Drug Hypersensitivity / Q000628:therapy*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D017239:Paclitaxel / Q000009:adverse effects* / Q000627:therapeutic use
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel